Many pharmaceutical products such as Gas Whalmyungsu, Fucidin ointment, Lacteol and Pancold A etc., have been developed after Dong-Wha Pharmaceutical Research Laboratories was founded in 1973. Since present laboratory building was built in 1985, our laboratory began to start the research systems for new drugs and advanced drugs. And now, approximately 100 scientists including other related employees are working together to develop new drugs, advanced drugs and new pharmaceutical products.
Our laboratory has been making the R & D strategis in the direction of catching up with the rapid changes of international situation. Based on the experience and technology accumulated until now, our laborotaory is maximizing the efficiency to new product development by sectionalization of and concentration to the projects cooperating with Industries / Universities / Research Institutes.
Based on these situations, our R & D projects are concentrated on the 3 kinds of therapeutic area for the new drug development ;
and new herbal drug development.
From the result of our R & D efforts, we have developed the new drug "Milican Injection" which is the world-first radiopharmaceutical drug for liver cancer and have made licencing out contracts of DW1350(candidate for treatment of osteoporosis) and DW224a(candidate for treatment of inflammation).
Dong-Wha was awarded [Korean World-Class Product Award 2001], [The 10 Best New Technologies of Year], [Dasan Technological Award], [Korea New Drug Award], [Dongam Award of Drug] and [Industry-University Cooperation Award] for the development of "Milican Injection".
We will grow into worldwide pharmaceutical company through developing the second, the third new drugs with competitive power in the world. |